Tower Research Capital (TRC)’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $141K | Sell |
|
|||||
|
2025
Q2 | $195K | Buy |
|
|||||
|
2025
Q1 | $52K | Sell |
|
|||||
|
2024
Q4 | $174K | Buy |
|
|||||
|
2024
Q3 | $95K | Sell |
|
|||||
|
2024
Q2 | $350K | Buy |
|
|||||
|
2024
Q1 | $18.4K | Sell |
|
|||||
|
2023
Q4 | $62.4K | Buy |
|
|||||
|
2023
Q3 | $31.9K | Sell |
|
|||||
|
2023
Q2 | $166K | Buy |
|
|||||
|
2023
Q1 | $98K | Sell |
|
|||||
|
2022
Q4 | $186K | Sell |
|
|||||
|
2022
Q3 | $589K | Buy |
|
|||||
|
2022
Q2 | $380K | Buy |
|
|||||
|
2022
Q1 | $263K | Sell |
|
|||||
|
2021
Q4 | $344K | Sell |
|
|||||
|
2021
Q3 | $559K | Buy |
|
|||||
|
2021
Q2 | $308K | Sell |
|
|||||
|
2021
Q1 | $622K | Sell |
|
|||||
|
2020
Q4 | $475K | Sell |
|
|||||
|
2020
Q3 | $1.52M | Buy |
|
|||||
|
2020
Q2 | $479K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $3K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $1K | Sell |
|
|||||
|
2017
Q3 | $50K | Buy |
|
|||||
|
2017
Q2 | $3K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $45K | Buy |
|
|||||
|
2016
Q3 | $2K | Sell |
|
|||||
|
2016
Q2 | $7K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $44K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $70K | Sell |
|
|||||
|
2015
Q1 | $71K | Buy |
|
|||||
|
2014
Q4 | $31K | Buy |
|
|||||
|
2014
Q3 | $18K | Sell |
|
|||||
|
2014
Q2 | $207K | Buy |
|
|||||
|
2014
Q1 | $13K | Buy |
|
|||||
|
2013
Q4 | $6K | Sell |
|
|||||
|
2013
Q3 | $114K | Buy |
|
|||||
|
2013
Q2 | $18K | Buy |
|